Don’t Put All Your Eggs In One Bubble
“It is easy enough to burst a bubble. To incise it with a needle so that it subsides gradually is an operation of undoubted delicacy.”… Read More »Don’t Put All Your Eggs In One Bubble
“It is easy enough to burst a bubble. To incise it with a needle so that it subsides gradually is an operation of undoubted delicacy.”… Read More »Don’t Put All Your Eggs In One Bubble
After having been hit hard earlier this year, tech stocks have regained some of what they lost, but they have not retaken the lead in… Read More »18 Cheap Tech Stocks Poised For A Comeback
The rewards from successful momentum investing can be substantial. Here are two “Strong Buy” stocks on upward trends that offer considerable upside potential. CLICK HERE.
Amid soaring valuations, it has become increasingly difficult to identify stocks that are truly cheap – i.e. underpriced relative to their true, intrinsic value. Here… Read More »The Good Kind Of Cheap In A Pricey Market
It’s no easy feat for a company to have been able to increase its dividend for at least 50 years in a row – through… Read More »The Latest Dividend Kings – And Some Potential Kings-In-Waiting
With the Pfizer vaccine having been approved, the Moderna vaccine all but certain to be approved, and the prospects of other key players in the… Read More »Is This The Best Bet In Biotech?
With higher dividend yields than the S&P 500 and outstanding metrics, these five quality tech stocks offer conservative growth investors solid total return potential with… Read More »“Solid Total Return Potential”: 5 Tech Stocks For Conservative Growth Investors
After initially being negatively impacted by the pandemic, several MedTech stocks are now benefitting from developments related to the crisis. Given COVID’s mixed impact on… Read More »After Several Mixed Months For MedTech Stocks, What’s The Best Strategy Now?
Small-cap stocks have been rallying. And with small-caps currently trading at the biggest discount to their large-cap counterparts in about 20 years – and the… Read More »Small-Caps’ Big Potential
Whether it’s for COVID-19 or any other disease or disorder, there’s one key number that investors need to focus on when it comes to study… Read More »The Key Number To Study In Vaccine Study Results